Back to compounds

COMPOUND PROFILE / SMALL MOLECULES

Dihexa.

Research draft

Dihexa is an experimental peptide-derived neuroactive compound.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Dihexa is an experimental peptide-derived neuroactive compound.

CLASSIFICATIONSmall molecules
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

HGF/c-Met-related activity has been proposed, but a central mechanism paper was retracted. The claim should not be presented as settled.

Human research

Direct therapeutic human evidence was not established.

Preclinical & other research

A foundational cognition and synaptic-mechanism paper was retracted in 2025. It is excluded as positive supporting evidence; the retraction is retained for transparency.

Safety & unknowns

Human safety is unknown; growth-factor pathway activity creates unanswered questions rather than proof of benefit.

Regulatory status

Research compound, not an established nootropic medicine.

Reported use & evidence

Research profile draft

The supplied Dihexa profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds